Blue 1

Blue 1, officially designated FD&C Blue No. 1 in the United States and E133 in the European Union, is a synthetic food colourant widely used to impart bright blue or blue-green hues to processed foods and beverages. It belongs to the triphenylmethane (triarylmethane) chemical family and is one of the most frequently used certified artificial colors in the global food supply.

First approved for food use in the United States in 1969, Blue 1 has undergone extensive safety evaluation by regulatory bodies including the U.S. Food and Drug Administration (FDA), the European Food Safety Authority (EFSA), and Health Canada. Current acceptable daily intake (ADI) values established by expert committees indicate that typical dietary exposure is well below levels of toxicological concern for the general adult population.

The colourant is highly water-soluble, stable across a broad pH range, and resistant to light and heat compared with many natural blue pigments, making it commercially attractive. It is found in a wide range of products including candies, soft drinks, ice creams, cereals, and pharmaceuticals. Its vivid color also makes it useful in cosmetics and personal-care products.

Public debate around Blue 1 has centred primarily on concerns about hyperactivity in children, cancer risk, and general safety of synthetic dyes. The weight of current evidence does not establish a causal link between Blue 1 at regulatory-approved intake levels and adverse health effects; however, some questions—particularly regarding individual sensitivity and neurobehavioural effects in children—remain areas of ongoing scientific inquiry.

Blue 1 belongs to the triphenylmethane class of synthetic dyes, characterised by a central carbon atom bonded to three aryl (phenyl-derived) ring systems. Its molecular structure features two diethylaminophenyl groups and one sulfonated phenyl group arranged around the central chromophore carbon. The intense blue-green color arises from strong visible-light absorption at approximately 630 nm, a consequence of extensive electron delocalisation across the conjugated π-system. Two sulfonate groups (–SO₃⁻) carried on the peripheral aryl rings confer high water solubility and are present as their sodium salts, making the commercial product a disodium salt. The structure also contains sulfonamide linkages introduced during synthesis. The chromophoric system is sensitive to strong reducing agents, which can bleach the dye by disrupting conjugation, and to extremes of pH that protonate or deprotonate key nitrogen atoms, shifting the absorption maximum.

Blue 1 is produced industrially through a multi-step synthetic route beginning with N-ethylaniline and formaldehyde as principal raw materials. In an initial condensation step, N-ethylaniline reacts with formaldehyde under acidic conditions to form a leuco (colourless) intermediate, specifically bis(N-ethylanilino)methane. This intermediate is then oxidised—typically using lead dioxide, sodium dichromate, or other oxidants—to generate the triphenylmethane chromophore. Sulfonation of the aryl rings is carried out using sulfuric acid or chlorosulfonic acid to introduce the sulfonate groups that provide water solubility. The resulting sulfonated dye base is then treated with sodium hydroxide or sodium carbonate to form the disodium salt and is precipitated or spray-dried to a powder. The final product must meet strict purity specifications set by regulatory authorities: for instance, the FDA's specifications under 21 CFR 74.101 limit lead, arsenic, mercury, and other heavy-metal contaminants to defined maximum concentrations. Batch certification—independent laboratory testing to confirm identity and purity—is mandatory for every production lot intended for use in food in the United States.

The synthetic dye industry that gave rise to Blue 1 began in the mid-19th century with the accidental discovery of mauveine by William Henry Perkin in 1856, which triggered rapid exploration of coal-tar-derived colorants for textiles. Triphenylmethane dyes, the class to which Blue 1 belongs, were developed extensively in the late 19th century. Erioglaucine—the compound now used as Blue 1—was initially commercialised as a textile dye in the 1890s. Its application to food and pharmaceuticals followed progressively as the food-colouring industry sought stable blue pigments, which are notoriously rare among natural pigments. In the United States, the Pure Food and Drug Act of 1906 initiated federal oversight of food dyes, and subsequent amendments to the Federal Food, Drug, and Cosmetic Act of 1938 established the certification system still in use today. Blue 1 was formally granted FD&C certification status in the USA in 1969. In Europe, it received E133 designation under EU food additive harmonisation directives. Since its approval, Blue 1 has been periodically re-evaluated by JECFA (Joint FAO/WHO Expert Committee on Food Additives) and EFSA, with its ADI confirmed and refined based on accumulating toxicological data.

• Vibrant blue colouration: Blue 1 produces an intense, clear blue to blue-green hue that is difficult to achieve with natural alternatives at comparable cost and stability.
• High stability: It resists fading under typical heat processing (pasteurisation, baking) and is reasonably light-stable, making it suitable for shelf-stable products.
• Broad pH compatibility: It maintains acceptable color across the mildly acidic to neutral pH range common in foods and beverages.
• Water solubility: Its high aqueous solubility facilitates easy incorporation into beverages, gels, icings, and syrups without the need for emulsification.
• Consumer appeal: Color strongly influences consumer perception of flavor, quality, and freshness; blue tones are associated with berry, mint, and blueberry flavor cues.
• Cost-effectiveness: Synthetic production yields a consistent, high-purity product at lower cost than natural blue pigments such as spirulina extract or indigo carmine from plant sources.
• Regulatory acceptance: Approval in major markets (USA, EU, Canada, Australia/NZ) simplifies global product formulation.
• Compatibility: It blends well with Yellow 5 and other certified dyes to create green and teal shades, expanding its formulation versatility.

Blue 1 is a food colourant added purely for aesthetic purposes and confers no established nutritional or physiological benefit to consumers. It provides no vitamins, minerals, antioxidants, or other bioactive compounds. Its sole function is sensory: to impart or intensify blue coloration in products. Some indirect arguments are sometimes made that appealing color may enhance consumer enjoyment of food or improve acceptance of otherwise unpalatable products (e.g., medications in paediatric formulations), but these are not health benefits attributable to the dye itself.

Established findings

• Low systemic absorption: Studies consistently show that Blue 1 is poorly absorbed from the gastrointestinal tract in humans; the majority is excreted unchanged in faeces, limiting systemic exposure.
• Hypersensitivity reactions: Rare allergic or hypersensitivity reactions, including urticaria and pruritus, have been reported in case series. A causal link is plausible given that similar triphenylmethane dyes are known sensitisers, but large-scale epidemiological confirmation is limited. (Established: rare, case-level evidence)

Limited or emerging evidence

• Neurobehavioural effects in children: The landmark 2007 McCann et al. study published in The Lancet found a statistically significant association between a mixture of six synthetic food dyes (not Blue 1 alone) plus sodium benzoate and increased hyperactivity in children. Blue 1 was not one of the six dyes tested, but the study raised broader questions about the dye class. EFSA's subsequent evaluation concluded the effect size was small and the mixture's composition complicated attribution. (Limited evidence; ongoing research)
• Possible blood-brain barrier permeation: An in-vitro rodent study suggested that at very high concentrations, Blue 1 injected directly may affect neural tissues, but dietary exposure via normal consumption routes does not produce such concentrations systemically. (Very limited evidence; not considered applicable to normal dietary exposure)

Unresolved questions

• Long-term cumulative dietary exposure in children: Children who consume large quantities of brightly coloured confectionery and beverages may have higher per-kg exposures than adults. Whether this elevates risk remains an active area of research, though current exposure estimates remain below the ADI for most populations.
• Interaction with other additives: The combined effects of multiple food additives consumed together (additive or synergistic interactions) are not well characterised for most dye combinations including Blue 1.

The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has established an Acceptable Daily Intake (ADI) of 0–6 mg/kg body weight per day for Blue 1. EFSA confirmed an ADI of 6 mg/kg bw/day in its 2010 re-evaluation. The FDA does not set a formal ADI but certifies the dye's safety within established use conditions.

For a 70 kg adult, the ADI corresponds to approximately 420 mg per day, a level that is very rarely approached through ordinary food consumption. Dietary exposure assessments in both the USA and EU consistently indicate that mean population intakes are well below this threshold, even among high consumers.

Children: Because children have lower body weight, a given absolute intake translates to a higher mg/kg dose. Regulatory exposure assessments specifically model high-percentile child consumers and generally find intakes remain below the ADI, though the margin of safety is smaller than for adults. Parents of children with attention-deficit/hyperactivity disorder (ADHD) are sometimes advised by clinicians to consider eliminating artificial dyes from the diet as a precautionary measure, though evidence for benefit is inconsistent.

Pregnancy and lactation: No specific ADI modification exists for pregnant or lactating women. Animal reproductive toxicity studies at doses far exceeding the ADI have not demonstrated teratogenicity; however, as with all non-essential additives, minimizing unnecessary exposure during pregnancy is a reasonable precautionary approach.

Hypersensitive individuals: Those who have experienced prior allergic reactions to triphenylmethane dyes should exercise caution and check food labels.

The bulk of peer-reviewed safety research on Blue 1 consists of regulatory toxicology studies conducted to support approval dossiers rather than independent academic investigation. Subchronic and chronic feeding studies in rats and dogs, conducted at doses orders of magnitude above estimated human dietary exposures, have not demonstrated carcinogenicity, reproductive toxicity, or teratogenicity attributable to Blue 1. JECFA's evaluations (most recently updated in its ongoing review cycle) and EFSA's 2010 opinion (EFSA Journal 2010;8(11):1853) represent the most comprehensive systematic reviews of available data. A frequently cited early concern was a 1980s-era study suggesting potential neurotoxic effects from direct intracerebral injection in rats; this route of exposure is wholly irrelevant to dietary consumption and is not considered in safety assessments. The McCann et al. (2007, The Lancet, doi:10.1016/S0140-6736(07)61306-3) study on mixed artificial dyes and hyperactivity generated substantial regulatory and public attention, but Blue 1 was not among the six dyes in the test mixture (which included Sunset Yellow, Quinoline Yellow, Carmoisine, Allura Red, Tartrazine, and Ponceau 4R), and its inclusion in broader hyperactivity discussions is largely inferential. Genotoxicity assays (Ames test, in-vitro chromosomal aberration, in-vivo micronucleus) have generally returned negative results for Blue 1. Absorption studies in humans and animals consistently confirm very low oral bioavailability, reducing concern about systemic toxicity. Overall, the body of evidence supports current regulatory conclusions that Blue 1 is safe at approved intake levels, while acknowledging that the database for certain endpoints (long-term epidemiological data in humans, mixture effects) is less robust than for some other additives.

Blue 1 has been subject to recurring public concern, largely driven by two narratives: the synthetic-versus-natural debate and the childhood hyperactivity controversy. Advocacy groups—most prominently the Center for Science in the Public Interest (CSPI) in the United States—have called for restrictions or bans on synthetic food dyes, citing the McCann et al. study and arguing that precautionary removal is warranted pending more definitive research. In 2011, following an FDA advisory committee review of the evidence on synthetic dyes and children's behavior, the committee concluded the available evidence did not support a causal link for the general population, though it acknowledged that some particularly sensitive children might benefit from dye elimination. The FDA did not mandate new labeling or restrictions as a result. In the UK, following the McCann study, the Food Standards Agency (FSA) recommended voluntary withdrawal of six specific dyes (the 'Southampton Six'); Blue 1 (E133) was not among those six dyes and was not the focus of that action. Online and social media spaces have amplified concerns about Blue 1 being 'toxic' or 'carcinogenic,' claims that are not supported by the preponderance of regulatory toxicology evidence. The ingredient is sometimes conflated with Blue 2 (Indigo Carmine / FD&C Blue No. 2), a structurally distinct dye with a different safety profile, leading to consumer confusion. Natural alternatives such as spirulina extract (phycocyanin) and butterfly pea flower extract are gaining market traction as 'clean-label' replacements, partly in response to consumer sentiment rather than documented safety concerns.

Blue 1, like other synthetic azo and triphenylmethane dyes, enters aquatic environments through industrial wastewater from manufacturing facilities and, to a lesser extent, through food-processing effluents and municipal sewage. Triphenylmethane dyes are generally resistant to conventional biological wastewater treatment due to their complex aromatic structure and chemical stability, meaning that without advanced treatment (ozonation, UV photodegradation, adsorption onto activated carbon, or advanced oxidation processes), they can persist in effluent streams. Environmental concentrations from food-use quantities are expected to be very low; the primary concern is manufacturing-site discharge. Ecotoxicological data on Blue 1 specifically are limited relative to azo dyes, but the general class of triphenylmethane dyes has been shown to exhibit toxicity to aquatic organisms (algae, invertebrates, fish) at elevated concentrations in laboratory settings. The relevance of these findings to real-world environmental concentrations from food applications has not been systematically established. Manufacturers in regulated markets are required to treat effluents to discharge standards; however, in regions with weaker enforcement, dye pollution from the textile and food industries can be significant. The sustainability profile of Blue 1 is also influenced by its petrochemical origin: it is derived from fossil-fuel-derived aniline and formaldehyde precursors, contributing a carbon footprint associated with chemical manufacturing.

Workers involved in the manufacture, handling, and formulation of Blue 1 may be exposed to the compound as a dust or aerosol. Triphenylmethane dyes are known skin and mucous-membrane irritants, and occupational dermatitis and respiratory sensitisation have been reported for color additive manufacturing workers more generally, though large-scale epidemiological studies specifically for Blue 1 manufacturing are lacking. Standard industrial hygiene practices—including engineering controls (enclosed processes, local exhaust ventilation), personal protective equipment (respiratory protection, gloves, and protective clothing), and biological monitoring—are recommended in facilities handling synthetic dye powders. Regulatory frameworks such as OSHA (USA) and REACH (EU) impose occupational exposure and chemical management requirements on manufacturers. No specific occupational exposure limit (OEL) appears to have been formally established for Blue 1 by major occupational health agencies, but general particulate exposure limits and precautionary measures apply.

Regulatory toxicology programs for Blue 1 have included subacute, subchronic (90-day), and chronic (2-year) dietary feeding studies in rats and dogs, as well as reproductive and developmental toxicity studies and genotoxicity batteries. In chronic rat studies at doses up to several hundred mg/kg bw/day—many times the established ADI—no carcinogenic signal attributable to Blue 1 was observed. Reproductive studies have not identified effects on fertility, litter parameters, or offspring development at high dietary doses. Genotoxicity assays (bacterial reverse mutation, chromosomal aberration in mammalian cells, in-vivo micronucleus) have predominantly returned negative results. A historical study involving direct intracerebral injection in rats suggested possible neurotoxic effects at high local concentrations; this finding is mechanistically irrelevant to oral dietary exposure, where systemic bioavailability is very low, and has not influenced regulatory conclusions. Oral absorption studies across species consistently demonstrate that the majority of ingested Blue 1 is not absorbed from the gut and is excreted in faeces, with a small fraction appearing in urine and bile in conjugated or degraded form. Overall, the animal database supports the safety of Blue 1 at doses far exceeding realistic human dietary exposure.

Direct human pharmacokinetic and clinical studies of Blue 1 are limited compared to the extensive animal database. Metabolic studies in human volunteers confirm very low oral bioavailability, consistent with animal data: the vast majority of ingested Blue 1 passes through the gastrointestinal tract unabsorbed. Small amounts are excreted in urine, indicating some degree of absorption and possible partial biotransformation, but systemic exposure remains minimal under ordinary dietary conditions. Epidemiological studies specifically investigating Blue 1 in isolation and human health outcomes are scarce; most hyperactivity and behavioural research has examined mixtures of synthetic dyes rather than individual compounds. Challenge studies in individuals reporting dye sensitivity have generally found objective evidence of reactivity to be uncommon and difficult to confirm under blinded conditions. EFSA's 2010 opinion noted the absence of robust human epidemiological data as a limitation but concluded that the animal toxicology database, combined with low human exposure estimates, provided sufficient basis for the ADI. Post-market surveillance data (adverse event reporting in the USA, EU rapid alert system RASFF) have not identified patterns consistent with widespread toxicity at typical exposure levels.

In the United States, Blue 1 must be declared on ingredient labels by its common name: FD&C Blue No. 1 or Blue 1. This requirement was established under the FDA's color additive labeling regulations (21 CFR 101.22). There is no requirement to list it as 'artificial color.'

In the European Union, Blue 1 must be labeled as Brilliant Blue FCF or by its E number, E133. Additionally, EU Regulation (EC) No 1333/2008 and related legislation require that food products containing any of the six 'Southampton Six' dyes carry the statement 'may have an adverse effect on activity and attention in children.' Blue 1 (E133) is not one of the Southampton Six, so this warning does not apply to Blue 1.

In Canada, it must be listed as FD&C Blue No. 1 or Brilliant Blue FCF in the ingredient list.

In Australia and New Zealand, it may be listed as Color (133) or Brilliant Blue FCF.

Manufacturers sometimes list it under alternative names such as Acid Blue 9 or Erioglaucine, though regulatory guidance generally favors standardized names. Consumers seeking to avoid Blue 1 should look for any of these designations on ingredient labels.

Blue 1 is a fully synthetic compound derived from petrochemical precursors; it does not occur naturally in any food, plant, or animal. There are no natural food sources of Brilliant Blue FCF itself. Natural blue pigments found in foods include anthocyanins (from blueberries, red cabbage, purple sweet potato, and butterfly pea flower), which produce blue-to-purple colors under neutral-to-alkaline pH conditions; phycocyanin from blue-green algae such as Spirulina platensis, increasingly used as a natural blue colourant; and indigoids such as indigo, historically derived from plants. None of these are chemically related to Blue 1 or belong to the triphenylmethane dye family.